Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0

Immunotherapy has been a pillar of the renal cell carcinoma (RCC) treatment landscape for over three decades. Some of the earliest cancer immunotherapies available, such as interleukin 2 and interferon-alpha, have resulted in complete responses, but only in a small number of patients. Immune checkpo...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tian Zhang, Shankar Siva, Wenxin Xu, Thomas Powles, Sabina Signoretti, Michael B Atkins, Sumanta K Pal, Rana R McKay, Toni K Choueiri, Brian I Rini, A Ari Hakimi, Brian Shuch, Arpita Desai, Pedro C Barata, Archana Ajmera, Cristiane Bergerot, Laura Bukavina, Susan Poteat, Wesley Yip
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2026-03-01
Colecção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/14/3/e013788.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!